Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15301-15350 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03820830
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer
PHASE3Active, not recruiting
405 participants
Started: Aug 27, 2019 · Completed: Jan 1, 2029
1 condition2 sponsors53 locations
NCT04067726
RANKL Inhibition and Mammographic Breast Density
PHASE2Active, not recruiting
210 participants
Started: Aug 27, 2019 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT04050410
Autonomic Determinants of POTS - Pilot1
EARLY_PHASE1Active, not recruiting
48 participants
Started: Aug 27, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03957551
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma
PHASE1/PHASE2Active, not recruiting
28 participants
Started: Aug 27, 2019 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT04215029
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
NAActive, not recruiting
6 participants
Started: Aug 27, 2019 · Completed: Jul 31, 2026
12 conditions3 sponsors1 location
NCT04053322
Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.
PHASE2Active, not recruiting
172 participants
Started: Aug 26, 2019 · Completed: Aug 31, 2027
2 conditions3 sponsors2 locations
NCT04157322
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
N/AActive, not recruiting
55 participants
Started: Aug 26, 2019 · Completed: Oct 31, 2025
4 conditions1 sponsor1 location
NCT04072588
Sacrospinous Ligament Fixation and Lateral Suspension Operations
N/AActive, not recruiting
80 participants
Started: Aug 24, 2019 · Completed: Aug 24, 2026
2 conditions1 sponsor1 location
NCT05782465
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
N/AActive, not recruiting
500 participants
Started: Aug 23, 2019 · Completed: Dec 31, 2033
1 condition8 sponsors8 locations
NCT03979131
Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)
PHASE2Active, not recruiting
40 participants
Started: Aug 22, 2019 · Completed: Jun 15, 2026
2 conditions1 sponsor1 location
NCT03924401
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
PHASE2Active, not recruiting
30 participants
Started: Aug 22, 2019 · Completed: Jan 31, 2026
1 condition5 sponsors9 locations
NCT03789240
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
PHASE2Active, not recruiting
33 participants
Started: Aug 22, 2019 · Completed: Jan 1, 2027
3 conditions1 sponsor1 location
NCT04132440
Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
N/AActive, not recruiting
17 participants
Started: Aug 22, 2019 · Completed: May 1, 2030
2 conditions2 sponsors1 location
NCT03733093
PREVAIL VIII: A CoHOrt Clinical, Viral, and ImmuNOlogic Monitoring Study of People Living With Retroviral Infection in Liberia (HONOR)
N/AActive, not recruiting
1,377 participants
Started: Aug 22, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT05087888
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
N/AActive, not recruiting
9 participants
Started: Aug 22, 2019 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT03914612
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
PHASE3Active, not recruiting
813 participants
Started: Aug 22, 2019 · Completed: Sep 26, 2026
16 conditions3 sponsors397 locations
NCT03904147
TRILUMINATE Pivotal Trial
NAActive, not recruiting
572 participants
Started: Aug 21, 2019 · Completed: Apr 30, 2029
1 condition1 sponsor76 locations
NCT03879629
Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart Failure
PHASE2Active, not recruiting
184 participants
Started: Aug 21, 2019 · Completed: Feb 28, 2027
1 condition3 sponsors5 locations
NCT04033237
Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women
PHASE1/PHASE2Active, not recruiting
66 participants
Started: Aug 21, 2019 · Completed: Jul 31, 2024
1 condition4 sponsors2 locations
NCT04023422
Clinic Navigation and Home Visits to Improve Guideline-based Care and Outcomes in Low Income Minority Adults With Asthma
NAActive, not recruiting
367 participants
Started: Aug 21, 2019 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations
NCT04044859
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
PHASE1Active, not recruiting
120 participants
Started: Aug 20, 2019 · Completed: Apr 30, 2037
9 conditions2 sponsors17 locations
NCT03873805
PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
PHASE1Active, not recruiting
14 participants
Started: Aug 20, 2019 · Completed: Apr 13, 2026
5 conditions2 sponsors1 location
NCT03971500
1-month vs 12-month DAPT for ACS Patients Who Underwent PCI Stratified by IVUS: IVUS-ACS and ULTIMATE-DAPT Trials
NAActive, not recruiting
3,710 participants
Started: Aug 20, 2019 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04002297
A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
PHASE3Active, not recruiting
510 participants
Started: Aug 20, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor176 locations
NCT04029974
Speed of Robotic Leg Movements and Orthostatic Hypotension in Subacute SCI
NAActive, not recruiting
35 participants
Started: Aug 20, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04038476
Transcutaneous Carbon-dioxide Monitoring in Electrophysiological Procedures in Deep Sedation
NAActive, not recruiting
726 participants
Started: Aug 20, 2019 · Completed: Nov 1, 2024
2 conditions1 sponsor1 location
NCT04465435
Sustainable UNiversity Life (SUN) Study
N/AActive, not recruiting
4,262 participants
Started: Aug 19, 2019 · Completed: Jan 31, 2032
2 conditions3 sponsors1 location
NCT03880019
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma
PHASE2Active, not recruiting
23 participants
Started: Aug 19, 2019 · Completed: Mar 6, 2026
3 conditions1 sponsor15 locations
NCT03621813
Exercise Rehabilitation in Veteran Cancer Survivors
NAActive, not recruiting
9 participants
Started: Aug 19, 2019 · Completed: Dec 30, 2026
1 condition2 sponsors1 location
NCT03906292
Frontline Asciminib Combination in Chronic Phase CML
PHASE2Active, not recruiting
125 participants
Started: Aug 19, 2019 · Completed: Dec 31, 2027
1 condition3 sponsors21 locations
NCT03980171
Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Aug 19, 2019 · Completed: Nov 30, 2026
1 condition1 sponsor3 locations
NCT03963154
Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation
PHASE1/PHASE2Active, not recruiting
7 participants
Started: Aug 19, 2019 · Completed: Dec 15, 2026
1 condition1 sponsor1 location
NCT04928586
Immunosuppressant Combined With Pirfenidone in CTD-ILD
PHASE4Active, not recruiting
200 participants
Started: Aug 16, 2019 · Completed: Jun 1, 2025
3 conditions1 sponsor1 location
NCT03994536
Effectiveness of a Transition Program for Adolescents With Type 1 Diabetes in the Transition to Adulthood
NAActive, not recruiting
140 participants
Started: Aug 15, 2019 · Completed: Jun 15, 2026
1 condition7 sponsors2 locations
NCT03785106
Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
PHASE3Active, not recruiting
2,500 participants
Started: Aug 15, 2019 · Completed: Mar 31, 2038
1 condition16 sponsors16 locations
NCT03870750
Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
PHASE2/PHASE3Active, not recruiting
458 participants
Started: Aug 15, 2019 · Completed: Dec 31, 2025
2 conditions3 sponsors11 locations
NCT03687359
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
N/AActive, not recruiting
1,860 participants
Started: Aug 15, 2019 · Completed: Jul 23, 2035
1 condition1 sponsor182 locations
NCT04028245
A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
EARLY_PHASE1Active, not recruiting
17 participants
Started: Aug 15, 2019 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT03426826
The Gut-Brain Study
PHASE1Active, not recruiting
10 participants
Started: Aug 15, 2019 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT03947229
A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial
PHASE4Active, not recruiting
3,200 participants
Started: Aug 14, 2019 · Completed: Aug 16, 2026
2 conditions1 sponsor1 location
NCT03952273
Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent
NAActive, not recruiting
3,141 participants
Started: Aug 14, 2019 · Completed: Nov 30, 2030
1 condition5 sponsors2 locations
NCT04055376
Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
NAActive, not recruiting
15 participants
Started: Aug 14, 2019 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT04062526
Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT
EARLY_PHASE1Active, not recruiting
11 participants
Started: Aug 14, 2019 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT04043195
Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Aug 14, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04033510
Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)
N/AActive, not recruiting
600 participants
Started: Aug 14, 2019 · Completed: Jan 30, 2027
6 conditions2 sponsors1 location
NCT03945747
MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus
N/AActive, not recruiting
50 participants
Started: Aug 14, 2019 · Completed: Aug 1, 2026
8 conditions4 sponsors1 location
NCT04280536
Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)
PHASE1/PHASE2Active, not recruiting
86 participants
Started: Aug 14, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03531645
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
PHASE2Active, not recruiting
18 participants
Started: Aug 13, 2019 · Completed: Sep 30, 2027
1 condition3 sponsors1 location
NCT04044768
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
PHASE2Active, not recruiting
52 participants
Started: Aug 13, 2019 · Completed: Apr 1, 2038
2 conditions1 sponsor26 locations
NCT03946878
Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
PHASE2Active, not recruiting
32 participants
Started: Aug 13, 2019 · Completed: Feb 8, 2026
9 conditions2 sponsors1 location